Showing results (81-90 of 1,629) with videos related to
Sort By:
Pageof 163
Expert Review of Clinical Pharmacology|July 5, 2016
An update on repurposed medications for the treatment of drug-resistant tuberculosisArnold Mafukidze, Elizabeth Harausz, Jennifer FurinExpert Review of Clinical Pharmacology|July 2, 2016
Targeted therapies in thyroid cancer: an extensive review of the literatureAthanasios Bikas, Shivangi Vachhani, Kirk Jensen, et al.Expert Review of Clinical Pharmacology|July 2, 2016
Canakinumab for the treatment of active systemic juvenile idiopathic arthritisJanet E Orrock, Norman T IlowiteExpert Review of Clinical Pharmacology|February 23, 2016
The efficiency of peptide immunotherapy for respiratory allergyCristoforo Incorvaia, Marcello Montagni, Erminia RidoloExpert Review of Clinical Pharmacology|March 3, 2018
Treatment of early stage chronic hepatitis C virus infectionFrancesca Romana Ponziani, Luca Miele, Annalisa Tortora, et al.Expert Review of Clinical Pharmacology|July 30, 2021
Vaccination and their importance for lung transplant recipients in a COVID-19 worldSamantha Scharringa, Thijs Hoffman, Diana A van Kessel, et al.Expert Review of Clinical Pharmacology|March 29, 2017
Fixed-ratio combination therapy with GLP-1 receptor agonist liraglutide and insulin degludec in people with type 2 diabetesLauge Østergaard, Christian Seerup Frandsen, Thomas Fremming Dejgaard, et al.Expert Review of Clinical Pharmacology|April 23, 2017
A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitusA Avogaro, A Giaccari, P Fioretto, et al.Expert Review of Clinical Pharmacology|October 28, 2016
Paracetamol and morphine for infant and neonatal pain; still a long way to go?Manuel A Baarslag, Karel Allegaert, John N Van Den Anker, et al.Expert Review of Clinical Pharmacology|October 11, 2016
Early drug development: assessment of proarrhythmic risk and cardiovascular safetyRobert M Lester, Joy OlbertzPageof 163